Agenda - Friday, January 17, 2020

7:30 - 8:00AM Registration & Check-in
8:00 - 9:30AM

Featured oral presentations of best abstracts

Chairs: Angie Fagerlin, PhD, Anna Catino, MD, and Rashmee Shah, MD

9:30-10:15AM

Keynote Address.

Elizabeth Hammond, MD

"The Impact of Dogmas in Medicine: The Case of Antibody-Mediated Rejection"

10:15 - 10:30AM

Break

10:30AM - 12:00PM

Invited Theme: Cardiorenal, End Organs, Systemic Milieu and Myocardial Recovery

Chairs: Aylin Rodan, MD/PhD, U of Utah and Kevin Shah, MD, U of Utah

Cardiorenal, end organs and heart failure: scope of the problem. Gerasimos Filippatos, MD, U of Cyprus & U of Athens

Innovation in the pathophysiology of cardiorenal syndrome. Jeff Testani, MD, Yale University

What happens to the Brain-CV-Renal axis when the circulation is mechanically supported? William Cornwell, MD, University of Colorado

Should we focus on the gut/microbiota and the kidney to recover the heart? Wilson Tang, MD, Cleveland Clinic

12:00 - 1:00PM

Lunch - Poster Viewing Session

1:00 - 2:00PM

The myocardial recovery field in the midst of a percutaneous revolution in valve therapy.

Chairs: Fred Welt, MD, U of Utah and Brent Wilson, MD/PhD, U of Utah

  1. Aortic stenosis-induced heart failure. Where is the point of no return for myocardial recovery and where for patient recovery? Anwar Tandar, MD, U of Utah (15min)
  2. What is the impact of repairing the mitral valve on myocardial function and structure? Brian Whisenant, MD, Intermountain Healthcare (15min)
  3. How to make sense of the conflicting results in mitral valve interventions: proportionate and disproportionate mitral regurgitation. Jerry Estep, MD, Cleveland Clinic ( (15 min)

Panel discussion (15 min) chairs and speakers

2:00 - 2:15PM

Break

2:15 - 3:45PM

Myocardial and Patient Recovery from Cardiogenic Shock: Unmet Needs Record-Field – Part A

(all talks will include an interactive case presentation)

Chairs: Evgenij Potapov, MD, Berlin Heart Institute & Joseph Tonna, MD, University of Utah Health

Do we need invasive hemodynamics/Swan-Ganz catheter in the management of cardiogenic shock? Joann Lindenfeld, MD, Vanderbilt

Cardiogenic shock requiring MCS: Catheter-based assist devices? VA-ECMO? Combination? Simon Maybaum, MD, Hofstra School of Medicine/Northwell Health

SHOCK TEAM: Institutional Cultural Change, Efficiency, Effectiveness & Other Challenges. S. Drakos, MD/PhD, U of Utah

3:45 - 5:30PM

Myocardial and Patient Recovery from Cardiogenic Shock: Unmet Needs Record-Field – Part B

Chairs: Ivan Netuka, MD, PhD, Prague, Czech Republic and Nir Uriel, MD, Columbia

Shock severity SCAI classification: How to “identify, communicate and predict” in the middle of the shock hurricane. David Baran, MD, Sentara

Identifying clinical and biological turning points to justify early short-term MCS. Stephen McKellar, MD, U of Utah

ECMO-CPR: Where is the point of no return? Dimitris Yannopoulos, MD, U of Minnesota

Featured Presentation - Putting Parts A & B Together: How to Advance the Shock Field Through Registries, RCTs and Other Ideas. Sean Van Diepen, MD, U of Alberta, Canada


 

Previous Conferences